EV Biotech Revenue and Competitors
Estimated Revenue & Valuation
- EV Biotech's estimated annual revenue is currently $4M per year.
- EV Biotech's estimated revenue per employee is $155,000
Employee Data
- EV Biotech has 26 Employees.
- EV Biotech grew their employee count by -40% last year.
EV Biotech's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO and founder | Reveal Email/Phone |
EV Biotech Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is EV Biotech?
EV Biotech is a microbial cell factory (MCF) strain development company. EV Biotech distinguishes itself by the use of state-of-the-art computational modelling. Using cutting-edge scientific developments in systems biology we create computational models of bacterial strains to predict most optimal strain modifications, growth media supplementation and scale up optimization in line with the rational design strategy. Fast-feedback loop between strain modellers and engineers increases development speed and efficiency of the MCF strain development pipeline. Preliminary models can be updated and enhanced quickly if needed, due to a close collaboration between a theoretical and experimental departments. On request EV Biotech can created highly effective compound production strains on demand. Contact us for an offer.
keywords:N/A
N/A
Total Funding
26
Number of Employees
$4M
Revenue (est)
-40%
Employee Growth %
N/A
Valuation
N/A
Accelerator
EV Biotech News
Low concentrations of asteltoxin inhibited EV secretion without inducing ... at 450 nm using an Immuno Mini NJ-2300 (Biotech, Tokyo, Japan).
Several other cutting-edge biotech companies have recently achieved RMAT ... a biotech company that uses extracellular vesicle (EV) platform...
... Visionary CEOs Highlight New Trends in Electric Vehicles, Biotech, ... According to BNEF, North America EV sales were up 97%...
Other Companies in Groningen
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 27 | 29% | N/A |
#2 | $2.6M | 27 | -53% | N/A |
#3 | N/A | 29 | 38% | N/A |
#4 | $7.2M | 36 | -12% | N/A |
#5 | $3.1M | 38 | 36% | N/A |